Published in Hypertens Res on November 15, 2012
Effect of Olmesartan-Based Therapies on Therapeutic Indicators Obtained Through Out-of-Office Blood Pressure. Cardiol Ther (2015) 0.75
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide. Vasc Health Risk Manag (2013) 0.75
Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide. Hypertens Res (2015) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension (2007) 2.90
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62
Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension (2008) 2.31
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24
Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension (2005) 2.05
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Carotid-femoral pulse wave velocity assessment by two different methods: implications for risk assessment. J Hypertens (2015) 1.98
Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens (2007) 1.86
Assessment and management of blood-pressure variability. Nat Rev Cardiol (2013) 1.84
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation (2011) 1.77
Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens (2011) 1.76
Blood pressure and obesity exert independent influences on pulse wave velocity in youth. Hypertension (2012) 1.70
Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study. J Hypertens (2011) 1.66
Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth. Hypertension (2009) 1.64
Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age. Hypertension (2014) 1.52
Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens (2012) 1.49
Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension (2012) 1.47
Effectiveness and safety of high-dose valsartan monotherapy in hypertension treatment: the ValTop study. Hypertens Res (2010) 1.45
2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) (2016) 1.42
Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis. J Hypertens (2007) 1.42
Effects of device-guided slow breathing training on exercise capacity, cardiac function and respiratory patterns during sleep in male and female patients with chronic heart failure. Pol Arch Med Wewn (2017) 1.39
Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. J Hypertens (2013) 1.39
[Renal function as a prognostic marker of mortality in heart failure]. Med Clin (Barc) (2009) 1.38
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood (2010) 1.37
Why Is Out-of-Office Blood Pressure Measurement Needed? Hypertension (2009) 1.32
Impact of telemonitoring at home on the management of elderly patients with congestive heart failure. J Telemed Telecare (2008) 1.17
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int (2009) 1.16
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care (2013) 1.16
Determinants of poor hypertension management in patients with ischaemic heart disease. Blood Press (2005) 1.13
Benefits of tight blood pressure control in diabetic patients with hypertension: importance of early and sustained implementation of effective treatment strategies. Diabetes Care (2011) 1.05
Blood pressure measurement in research and in clinical practice: recent evidence. Curr Opin Nephrol Hypertens (2004) 1.04
Blood pressure variability: assessment, predictive value, and potential as a therapeutic target. Curr Hypertens Rep (2015) 1.02
Blood pressure variability, cardiovascular risk, and risk for renal disease progression. Curr Hypertens Rep (2012) 1.00
Assessment of overall blood pressure variability and its different components. Blood Press Monit (2003) 0.99
Device-guided paced breathing in the home setting: effects on exercise capacity, pulmonary and ventricular function in patients with chronic heart failure: a pilot study. Circ Heart Fail (2008) 0.95
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens (2013) 0.94
The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens (2006) 0.93
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens (2012) 0.93
What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. EuroIntervention (2014) 0.92
Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population. PLoS One (2012) 0.92
European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens (2009) 0.91
The pulsatile component of blood pressure: its role in the pathogenesis of atherosclerosis. Blood Press (2007) 0.90
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens (2007) 0.88
Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes? Diabetes Care (2009) 0.88
Italian society of hypertension guidelines for conventional and automated blood pressure measurement in the office, at home and over 24 hours. High Blood Press Cardiovasc Prev (2013) 0.87
Disappearance of isocapnic buffering period during increasing work rate exercise at high altitude. Eur J Cardiovasc Prev Rehabil (2008) 0.87
Xanthine oxidoreductase polymorphisms: influence in blood pressure and oxidative stress levels. Pharmacogenet Genomics (2007) 0.86
Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens (2008) 0.86
Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study. J Hypertens (2006) 0.85
Home blood pressure control is low during the critical morning hours in patients with hypertension: the SURGE observational study. Fam Pract (2011) 0.85
Calcium antagonist added to angiotensin receptor blocker: a recipe for reducing blood pressure variability?: evidence from day-by-day home blood pressure monitoring. Hypertension (2012) 0.85
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens (2014) 0.85
New developments in the pathogenesis of obesity-induced hypertension. J Hypertens (2015) 0.84
Association of a mineralocorticoid receptor gene polymorphism with hypertension in a Spanish population. Am J Hypertens (2009) 0.84
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. J Hypertens (2010) 0.84
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens (2016) 0.83
Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention (2013) 0.83
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens (2016) 0.83
High-altitude exposure of three weeks duration increases lung diffusing capacity in humans. J Appl Physiol (1985) (2011) 0.83
Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol (2012) 0.83
Nocturnal blood pressure versus nondipping pattern: what do they mean? Hypertension (2007) 0.83
Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia. BMC Public Health (2010) 0.82
Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population. Eur J Clin Invest (2011) 0.82
Non-invasive beat-to-beat blood pressure monitoring: new developments. Blood Press Monit (2003) 0.82
Measurement of microalbuminuria--what the nephrologist should know. Nephrol Dial Transplant (2005) 0.81
Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension (2005) 0.81
The impact of birth weight on pulse pressure during adolescence. Blood Press Monit (2004) 0.81
Dietary polyunsaturated fatty acids may increase plasma LDL-cholesterol and plasma cholesterol concentrations in carriers of an ABCG1 gene single nucleotide polymorphism: study in two Spanish populations. Atherosclerosis (2011) 0.80
Acute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project. Respir Physiol Neurobiol (2013) 0.80
Office and 24-h ambulatory blood pressure control by treatment in general practice: the 'Monitoraggio della pressione ARteriosa nella medicina TErritoriale' study. J Hypertens (2010) 0.80